急性心肌梗塞溶栓治疗课件.pptVIP

Combination Lytic Therapy inAcute Myocardial Infarction;Pathophysiology of Combination Therapy in AMI;Recent Clinical Trials;Clinical Trials: Ongoing;54%;TIMI Grade 3 Flow – Pooled Data From Dose Confirmation Phases of Recent Trials;SPEED: Results of Dose-Confirmation Phase;GUSTO-V: Study Design;Primary End Point: 30-Day Mortality ;GUSTO-V: Noninferiority Analysis;A Comparison of the Outcomes With r-PA Monotherapy in GUSTO-III vs GUSTO-V Trials;0.2;Non-Intracranial Bleeding Through Discharge/Day 7;ICH by Age Group;*;2.8;GUSTO-V: Conclusions;ASSENT-3: Rationale for Use of Enoxaparin ;ASSENT-3: